These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 7911254

  • 1. Treatment of ovarian cancer: current status.
    Ozols RF.
    Semin Oncol; 1994 Apr; 21(2 Suppl 2):1-9; quiz 10, 58. PubMed ID: 7911254
    [Abstract] [Full Text] [Related]

  • 2. Current status of chemotherapy for ovarian cancer.
    Ozols RF.
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):61-6. PubMed ID: 7481863
    [Abstract] [Full Text] [Related]

  • 3. The role of paclitaxel in the management of coelomic epithelial carcinoma of the ovary: a review with emphasis on the Gynecologic Oncology Group experience.
    Thigpen T, Vance RB, McGuire WP, Hoskins WJ, Brady M.
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):23-31. PubMed ID: 8553080
    [Abstract] [Full Text] [Related]

  • 4. Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer. German AGO Study Group Ovarian Cancer. Arbeitsgemeinschaft Gynäkologische Onkologie.
    du Bois A, Lück HJ, Meier W, Möbus V, Costa S, Richter B, Bauknecht T, Warm M, Schroeder W, Olbricht S, Nitz U, Jackisch C.
    Semin Oncol; 1997 Aug; 24(4 Suppl 11):S11-28-S11-33. PubMed ID: 9314296
    [Abstract] [Full Text] [Related]

  • 5. Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer.
    Ozols RF.
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):3-7. PubMed ID: 10952119
    [Abstract] [Full Text] [Related]

  • 6. Chemotherapy of advanced ovarian cancer: current status and future directions.
    Ozols RF, Vermorken JB.
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-1-S2-9. PubMed ID: 9045324
    [Abstract] [Full Text] [Related]

  • 7. Gynecologic oncology group trials in ovarian carcinoma.
    Ozols RF.
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-10-S2-12. PubMed ID: 9045325
    [Abstract] [Full Text] [Related]

  • 8. Paclitaxel plus carboplatin in the treatment of ovarian cancer.
    Ozols RF.
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):84-9. PubMed ID: 10190787
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy for advanced ovarian cancer: overview of randomized trials.
    Thigpen JT.
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):11-6. PubMed ID: 10952121
    [Abstract] [Full Text] [Related]

  • 10. Current status and future directions of platinum/paclitaxel-based chemotherapy of ovarian cancer.
    Markman M.
    Semin Oncol; 1997 Aug; 24(4 Suppl 11):S11-24-S11-27. PubMed ID: 9314295
    [Abstract] [Full Text] [Related]

  • 11. Rationale for examining the combination of paclitaxel and ifosfamide in the treatment of advanced ovarian cancer.
    Markman M.
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):88-9. PubMed ID: 7597438
    [Abstract] [Full Text] [Related]

  • 12. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.
    du Bois A, Lück HJ, Meier W, Möbus V, Costa S, Richter B, Warm M, Bauknecht T, Schröder W, Olbricht S, Nitz U, Jackisch C.
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel/carboplatin for the initial treatment of advanced ovarian cancer.
    Neijt JP, du Bois A.
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):78-83. PubMed ID: 10190786
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
    Skarlos DV, Aravantinos G, Kosmidis P, Athanassiadis A, Stathopoulos GP, Pavlidis N, Bafaloukos D, Karphathios S, Papakostas P, Bamia C, Fountzilas G.
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
    [Abstract] [Full Text] [Related]

  • 15. Chemotherapy of advanced ovarian cancer.
    Martoni A, Cacciari N, Angelelli B, Zamagni C, Pannuti F.
    Front Biosci; 1997 Mar 15; 2():g20-6. PubMed ID: 9159262
    [Abstract] [Full Text] [Related]

  • 16. Gynecological malignancies.
    Schaebler DL, Schilder RJ, Young RC.
    Cancer Chemother Biol Response Modif; 1996 Mar 15; 16():564-91. PubMed ID: 8639401
    [Abstract] [Full Text] [Related]

  • 17. The current role and future prospects of paclitaxel in the treatment of small cell lung cancer.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1999 Feb 15; 26(1 Suppl 2):60-6. PubMed ID: 10190785
    [Abstract] [Full Text] [Related]

  • 18. Combination regimens of paclitaxel and the platinum drugs as first-line regimens for ovarian cancer.
    Ozols RF.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 15):1-6. PubMed ID: 8643963
    [Abstract] [Full Text] [Related]

  • 19. Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer: a phase I trial.
    Meerpohl HG, du Bois A, Luck HJ, Kühnle H, Möbus V, Kreienberg R, Bauknecht T, Köchli O, Bochtler H, Diergarten K.
    Semin Oncol; 1997 Feb 15; 24(1 Suppl 2):S2-17-S2-22. PubMed ID: 9045330
    [Abstract] [Full Text] [Related]

  • 20. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
    Ozols RF.
    J Natl Compr Canc Netw; 2004 Sep 15; 2 Suppl 2():S60-73. PubMed ID: 19780247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.